Literature DB >> 3185120

Biosynthesis of membrane cholesterol during peripheral nerve development, degeneration and regeneration.

J K Yao1.   

Abstract

Biosynthesis of peripheral nerve cholesterol was investigated by the in vivo and in vitro incorporation of [1-14C]-acetate into sciatic endoneurium of normal rats during development, degeneration and regeneration. Labeled sterols were rapidly formed (less than 10 min) within the endoneurial portion of sciatic nerve after [1-14C]acetate administration by intraneural injection. The majority of labeled sterols were initially found in lanosterol and desmosterol. After six hr, the 14C-labeling in both precursors was decreased to minimum, whereas cholesterol became the major labeled product of sterol. As myelination proceeded, the incorporation of [1-14C]acetate into endoneurial cholesterol decreased rapidly and reached a minimum after six mo. In mature adult nerve, an increased proportion of biosynthesis of lanosterol and desmosterol also was demonstrated. The in vitro incorporation of [1-14C]acetate into cholesterol was inhibited during Wallerian degeneration. Instead, cholesteryl esters were labeled as the major sterol product. Such inhibition, however, was not observed in the adult Trembler nerve (Brain Res. 325, 21-27, 1985), which is presumed to be due to a primary metabolic disorder of Schwann cells. The cholesterol biosynthesis was gradually resumed in degenerated nerve by either regeneration of crush-injured nerve or reattachment of the transected nerve. These results suggest that cholesterol biosynthesis in peripheral nerve relies on the axon to provide necessary substrates. De novo synthesis appears to be one of the major sources of endoneurial cholesterol that forms and maintains peripheral nerve myelin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3185120     DOI: 10.1007/bf02536205

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  32 in total

1.  Myelin synthesis in vitro: a comparative study of central and peripheral nervous tissue.

Authors:  F A Rawlins; M E Smith
Journal:  J Neurochem       Date:  1971-10       Impact factor: 5.372

2.  Reutilization of cholesterol-1,2-H3 in the regeneration of peripheral nerve. An autoradiographic study.

Authors:  F A Rawlins; E T Hedley-Whyte; G Villegas; B G Uzman
Journal:  Lab Invest       Date:  1970-03       Impact factor: 5.662

3.  Cholesterol esters and hydrolytic cholesterol esterase during Wallerian degeneration.

Authors:  C Mezei
Journal:  J Neurochem       Date:  1970-08       Impact factor: 5.372

4.  The incorporation of cholesterol into the nervous system of the newly hatched chick.

Authors:  O Svanberg
Journal:  Acta Physiol Scand       Date:  1970-09

Review 5.  Membrane cholesterol, tumorigenesis, and the biochemical phenotype of neoplasia.

Authors:  P S Coleman; B B Lavietes
Journal:  CRC Crit Rev Biochem       Date:  1981

6.  Nerve xenografts to apportion the role of axon and Schwann cell in myelinated fiber absence in hereditary sensory neuropathy, type II.

Authors:  P J Dyck; A C Lais; M F Sparks; K F Oviatt; A L Hexum; D Steinmuller
Journal:  Neurology       Date:  1979-09       Impact factor: 9.910

7.  The sequential alterations of endoneurial cholesterol and fatty acid in Wallerian degeneration and regeneration.

Authors:  J K Yao; V Natarajan; P J Dyck
Journal:  J Neurochem       Date:  1980-10       Impact factor: 5.372

8.  [14C]acetate metabolism in the peripheral nervous system.

Authors:  J K Yao; K P Cannon
Journal:  Biochim Biophys Acta       Date:  1983-10-11

9.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

10.  Hereditary hypertrophic neuropathy in the trembler mouse. Part 2. Histopathological studies: electron microscopy.

Authors:  P A Low
Journal:  J Neurol Sci       Date:  1976-12       Impact factor: 3.181

View more
  2 in total

1.  Metabolism of peripheral nerve monogalactosylceramides.

Authors:  J K Yao
Journal:  Lipids       Date:  1989-10       Impact factor: 1.880

2.  Identifying Novel Psoriatic Disease Drug Targets Using a Genetics-Based Priority Index Pipeline.

Authors:  Audrey Bui; Jared Liu; Julie Hong; Edward Hadeler; Megan Mosca; Nicholas Brownstone; Wilson Liao
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2021-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.